Meta-analysis: Immunogenicity, Effectiveness, and Safety of Measles Vaccination in Infants Younger than 9 Months

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis – The Lancet Infectious Diseases (free)

Related Article: Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis – The Lancet Infectious Diseases (free)

Invited Commentary: Early vaccination: a provisional measure to prevent measles in infants (free)

Related Commentary on Twitter

Recommending measles vaccination to infants younger than 9 months for those at high risk of measles is an important step towards reducing measles-related mortality and morbidity: a systematic review and meta-analysis – Lancet Infect Dis ⁦⁦@rivm⁩ https://t.co/HDHi8ULz6u

— Annemarie van Rossum (@amcvanrossum) September 22, 2019